adenosine diphosphate ribose has been researched along with Prostatic Neoplasms, Castration-Resistant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Liu, Y; Luo, H; Shao, C; Yu, B; Zhang, C | 1 |
| Cheng, HH; Higano, CS | 1 |
| Agarwal, N; Efstathiou, E; Engelsberg, A; Fizazi, K; Saad, F; Sayegh, N; Zhang, T | 1 |
2 review(s) available for adenosine diphosphate ribose and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Poly-ADP ribose polymerase inhibitor and androgen receptor signaling inhibitor for all comers for first-line treatment of metastatic castration-resistant prostate cancer: is gene sequencing out?
Topics: Adenosine Diphosphate Ribose; Antineoplastic Agents; Humans; Male; Poly(ADP-ribose) Polymerase Inhibitors; Prostatic Neoplasms, Castration-Resistant; Randomized Controlled Trials as Topic; Receptors, Androgen | 2023 |
The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer.
Topics: Adenosine Diphosphate Ribose; Androgen Receptor Antagonists; Androgens; Biology; Humans; Male; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms, Castration-Resistant; Randomized Controlled Trials as Topic; Receptors, Androgen | 2023 |
1 other study(ies) available for adenosine diphosphate ribose and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Androgen receptor splicing variant 7 (ARv7) promotes DNA damage response in prostate cancer cells.
Topics: Adenosine Diphosphate Ribose; Alternative Splicing; Androgen Antagonists; Cell Line, Tumor; DNA Damage; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen | 2022 |